Taking stock of the drug industry, from the lab to the medicine chestJuly 21, 2023Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Chris Seward/AP STAT+ | Pfizer says most tornado damage at key plant hit warehouse, but finished drugs also impacted Pfizer says a tornado that ripped through a manufacturing plant does not appear to have caused major damage to areas that produce medicines. By Ed Silverman STAT+ | European regulator will review study data from contract research organization due to 'serious concerns' The European Medicines Agency is reviewing studies conducted by Synapse Labs, a CRO, due to questions about its study data. By Ed Silverman Europe recommends the approval of Pfizer's RSV vaccine for older adults and in pregnancy European regulators on Friday recommended the approval of Pfizer's RSV vaccine both for older adults and for use in pregnancy. By Andrew Joseph Elise Amendola/AP Providers still hesitate to prescribe buprenorphine for addiction, despite 'X-waiver' removal Despite the removal of the "X-waiver" for buprenorphine, doctors cite other barriers to medication treatment for opioid addiction. By Lev Facher STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments